inflammatory/infectious conditions such as AIDS, syphilis, human T-cell leukemia virus type 1 (tropical spastic paraplegia), metabolic diseases such as arginase deficiency, homocysteinemia, vitamin B12 deficiency, vitamin E deficiency, copper deficiency, serine deficiency, leukodystrophies (Krabbe's disease, adrenoleukodystrophy, metachromatic leukodystrophy), among others 4, 5, 6 . The brain scan is often normal, but possible anomalies include thinning of the corpus callosum, cerebellar atrophy, and nonspecific changes in the white matter 3 . Over 70 distinct loci and over 50 genes have been identified in the genesis of the disease 7 . Thus, each type of HSP is named as SPG (spastic paraplegia gene) followed by the number representing the chronological order of identification of the genetic locus. Transmission may be recessive, dominant, X-linked or mitochondrial 8, 9, 10 . There is a consensus among authors that the transmission of HSP-S is usually autosomal dominant, whereas HSP-C is autosomal recessive 11 .
In individuals where the symptoms begin in childhood, disease progression tends to be very slow, resembling nonprogressive chronic encephalopathy (cerebral palsy), which is the main differential diagnosis in children with spastic paraplegia 12 . The American Academy of Neurology recommends that metabolic and genetic testing should be considered in children with spastic paraplegia if their clinical record or neuroimaging findings are insufficient for establishing a specific diagnosis, or if there are other additional atypical features in their history or clinical examination 13 . Therefore, the diagnosis of HSP should be considered in those children with spastic paraplegia whose pathogenic mechanisms remain obscure after laboratory investigation.
Studies involving HSP in children are scarce in the international literature. A recent study on historical aspects of these diseases points out the absence of such studies in Brazil 14 . Our goals were to highlight the clinical and epidemiological aspects of pediatric HSP in a Brazilian sample.
METHODS
Clinical, observational and analytical studies were performed in patients with a clinical diagnosis of HSP, followed up between 2003 and 2016 at the Neuropediatric Division of Santa Casa de São Paulo, Brazil.
The analyzed data were: sex, skin color, age at onset of symptoms, age at first appointment, time elapsed between onset of symptoms and final diagnosis, and family history. Patients were clinically examined and classified as having pure or complicated spastic paraplegia, based on established diagnostic criteria 1, 3 . Patients were characterized as having a progressive condition if, during their follow-up, worsening of their motor condition was detected through the neurological examination including the Medical Research Council scale. The date of onset of symptoms was provided by the mother or guardian. Intellectual disability (intellectual development disorder) was diagnosed in children older than five years at the time of data collection according to DSM-5 criteria 15 . Magnetic resonance imaging (MRI) of the brain and spinal cord, electromyography, cerebrospinal fluid, fundoscopy, auditory assessment with audiometry or auditory evoked potentials (depending on the patient's collaboration), human T-cell leukemia virus type 1, HIV and Venereal Disease Research Laboratory serologies, serum levels of vitamin B12, vitamin E, copper, ceruloplasmin, ammonia, homocysteine and arginine were performed. Depending on the clinical presentation, hexosaminidase A, galactocerebrosidase, serum immunoglobulins, alpha-fetoprotein, electrocardiogram or peripheral blood acanthocyte analysis were also performed. After this comprehensive clinical and laboratory screening, the patients who did not fit the diagnosis of HSP were excluded from the sample. The examinations are listed in Figure 1 .
Statistical analysis
The SPSS software, version 13.0, was used for conducting the statistical analysis. In the descriptive analysis, absolute and relative frequencies were used for qualitative variables, whereas summary measures were used for quantitative variables. Normality of the data was tested with the Shapiro-Wilk test and nonparametric tests were used for non-normally distributed data. For the statistical inference, the following tests were conducted: Fisher's exact test (small sample size) or chi-squared (qualitative X qualitative variables), in addition to the nonparametric Student's t and Mann-Whitney tests (quantitative variables X simple or complicated group). Statistical significance was defined as p < 0.05. The statistical study was carried out by the Department of Statistics of the graduate program of the School of Medicine at Santa Casa de São Paulo.
Research ethics committee
Guardians, parents and patients agreeing to participate in the study signed a voluntary and informed consent form. 
RESULTS

Epidemiological and clinical data
Thirty-five patients were studied, of whom 12 (34.2%) had HSP-S and 23 (65.8%) had HSP-C.
Simple hereditary spastic paraplegia -HSP-S
Of the 12 patients, seven (58.3%) were male and five (41.7%) were female. Six patients (50%) were white, four (33.3%) were brown, one (8.3%) was yellow and one patient (8.3%) was black.
Regarding family history, four (33.3%) had at least one affected relative, such as parent or grandparent and two (16.6%) had a history of parental consanguinity.
The mean age at onset of symptoms was 2.9 years (ranging from 0.8 to 10.8 years), with a median of 1.5 years. The mean age at the time of the first appointment in our outpatient service was 5.1 years (minimum 1.5 and maximum 11.9 years of age), with a median of 4.9 years. The mean time between onset of symptoms and diagnosis was three years, with a median of two years (the minimum age was 0 and the maximum age was 8.2 years).
Seven (58.3%) reported progression of their symptoms during follow-up, while five (41.7%) did not report any motor worsening.
Eleven patients (91.6%) had independent gait at the last neurological evaluation, whereas one patient (8.3%) needed support to ambulate. This patient, first seen at age 11, is now 25 years old and has required a wheelchair since age 21. The clinical and epidemiological data are listed in Table 1 .
Complicated hereditary spastic paraplegia -HSP-C
Of the 23 patients, 11 (47.8%) were male and 12 (52.1%) were female. Eleven patients (47.8%) were brown, 10 (43.5%) were white, and two patients (8.6%) were black.
Regarding their family history, nine patients (39.1%) had at least one affected relative (seven had affected siblings and two had an affected uncle and cousin). In this sample, there were two pairs of siblings. Four patients (17.4%) had a history of parental consanguinity.
The mean age at onset of symptoms was 1.6 years (ranging from 0 to 11 years), with a median of one year. The mean age at the time of the first appointment was 4.3 years (minimum 0.5 and maximum 15.2 years of age), with a median of 2.2 years. The mean time between onset of symptoms and diagnosis was 6.4 years, with a median of 5.5 years (ranging between 0.8 and 14.4 years of age).
Seventeen patients (73.9%) reported progression of their clinical condition, while six patients (26.0%) did not report any worsening. Eight patients (34.8%) had independent gait at the last neurological evaluation, whereas seven patients (30.4%) needed support to ambulate, and eight (34.8%) were restricted to a wheelchair, five of whom have never walked. One of these patients has a sister diagnosed as having an HSP-S phenotype.
Complicated HSP was most frequently associated with intellectual disability. The associated clinical symptoms and signs are listed in Figure 2 . Of the 23 patients, 20 (87%) had intellectual disability, two (8.6%) had a normal intelligence until the time of data collection, but one patient could not be assessed due to his age. Six patients (26%) reported epileptic seizures at some time in their life ( febrile seizure in one, isolated seizure in one and recurrent in four). The clinical and epidemiological data are listed in Table 2 .
HSP-S versus HSP-C
There were no statistical differences between the simple and complicated groups in relation to skin color, sex, presence or absence of familial cases, and age at first appointment. However, there was a statistically significant difference (p < 0.05) regarding the age of onset of symptoms and the time elapsed between the onset of symptoms and final diagnosis between the two groups. In the HSP-C group, the disease manifested earlier and the diagnosis was later (the statistical tests and variables are listed in Table 3 ).
Neuroimaging findings
All patients underwent brain MRI. Scans were normal in all patients with HSP-S. In patients with HSP-C, scans were normal in 10 (43.4%) patients, whereas in six (26.1%) patients nonspecific changes were present in white matter; in four (17.4%) there was a thin corpus callosum, in three of whom the "ears of the lynx" sign was observed ( Figure 3) ; in two (8.7%) cerebellar atrophy; and in one (4.3%) nonspecific signal changes in the basal ganglia were identified. Spinal cord MRI was performed in 21 patients (12 in the HSP-S group and nine in the HSP-C group). Hemangioma without spinal cord compression (n = 1), spina bifida without spinal cord involvement (n = 1), and hyperintensity of the lumbar roots following contrast injection (n = 1) were individually encountered in three patients of the HSP-C group.
Electroneuromyography findings
Eight patients of the HSP-S group were tested, with normal results. From 13 patients of the HSP-C group who were tested, a symmetric, length-dependent, and dying-back pattern characteristic of axonal peripheral polyneuropathy was noted in three individuals (two with purely motor, and one with motor and sensory impairment).
Fundoscopic findings
All patients but one in the HSP-S group had a fundoscopic examination. The results were normal. This examination was performed in 20 patients of the HSP-C group. Pale papillae were present in two and optic atrophy was found in one.
Audiology findings
Twenty patients underwent auditory assessment with audiometry or evoked potentials (eight from the HSP-S group and 12 from the HSP-C group). Sensorineural hearing loss was detected in one patient in the HSP-C group.
DISCUSSION
The diagnosis of HSP in children poses several problems. Often, the progression of the symptoms is very slow, mimicking the diplegic form of cerebral palsy. Absence of a positive family history due to de novo mutations or lack of recognition Table 3 . Statistical analysis of the variables in HSP-S and HSP-C groups. of the disease in relatives is a common event. Other neurological diseases (inflammatory, metabolic, degenerative) may be clinically similar. Therefore, in children with a suspected clinical diagnosis of HSP, a complete battery of tests must be performed to achieve the correct diagnosis. Our sample of 35 children, selected after careful clinical and laboratory studies, may be considered as having HSP with a very high degree of probability even in the absence of genetic tests (which are not always conclusive).
There are only a few studies devoted to pediatric HSP (Table 4) . Two of them analyzed only the simple form of HSP 7, 16 , and the other two studied both HSP-S and HSP-C 17, 18 . The correlation among their and our findings is shown in Table 4 . In the two series by Koul et al. 17 and Kumar et al.
18
, the frequency of HSP-C is somewhat higher. The high frequency of familial cases in the series by Koul et al. may be due to the high rate of parent consanguinity in their cohort.
In our series, the onset of the disease occurred earlier in the HSP-C patients. This finding could be due to the fact that associated neurological abnormalities in HSP-C may have facilitated earlier identification of the disease.
The mean time elapsed between the disease onset and the final diagnosis was longer in HSP-C patients (three years in HSP-S and 6.4 years in HSP-C). This delay was probably due to the complexity of the associated symptoms and the multiple differential diagnostic tests.
Motor impairment was less severe in the HSP-S group, all patients being ambulatory with or without support, whereas most of the HSP-C patients were wheelchair-dependent.
Intellectual disability was the most frequent event associated with HSP in the complicated form. In our series, this association was present in 87% of the patients. In the series by Koul et al. 17 , this number was lower (40%). This discrepancy may be explained by the lack of standardized criteria for intellectual disability assessment, and by the fact that, in this series, 60% of the children were below the age of one year.
Thinning of the corpus callosum, when present, occurs in autosomal recessive HSP-C, and mutation of the SPG11 gene is frequently encountered 19, 20 . In our series, this malformation was found in four patients, three of whom showed the "ears of the lynx" sign, which was recently described 21 . Autosomal recessive inheritance may be considered in two of these patients because parental consanguinity was detected in one and another had an affected sibling.
Although previously described in a series including mainly adult patients 22 , reduction of the volume of the spinal cord was not present in any of our patients, or in the pediatric patients studied by Koul et al. 17 . However, it should be stated that although the radiology evaluation was carried out by an experienced neuroradiologist, volumetric analysis according to the criteria described by Hedera et al. 22 was not performed. Furthermore, spinal cord atrophy could be a late event in the clinical course of the disease.
Peripheral neuropathy was present in three HSP-C patients, one of whom had associated intellectual disability, thin corpus callosum, and nonspecific changes in the white matter. Peripheral neuropathy has been previously described in patients with HSP-C 23 . It is known that there are mutations in genes such as ATL1 (SPG3A) and BSCL2 (SPG17) responsible for either HSP or Charcot Marie Tooth disease 24 . One patient of this series, classified as HSP-C, has a sister with HSP-S. This may be evidence that the same genetic mutation may be responsible for different phenotypes 25 . Indeed, this phenomenon has been highlighted as more and more genetic mutations are being discovered.
The concept that there is a continuum between HSP and other neurodegenerative diseases has been previously postulated 26 .
No pathogenic genetic anomaly was identified in the exome sequencing performed in one patient with HSP-S phenotype. This finding is not surprising as inconclusive results on genetic analysis, carried out with different techniques such as exome sequencing, genome sequencing or assessment of specific mutation depending on the patient phenotype, occur in one-third to half of the patients 17, 27 . In one series comprising HSP-S sporadic patients, positive molecular diagnosis was achieved in only 28% 28 . Thus, the necessity of a rigorous evaluation of the patients in order to reach a secure diagnosis on clinical grounds is obvious. This is particularly necessary in pediatric patients where the clinical diagnosis is much more difficult than in adults. Working in the way we have done in this study, it was possible to select patients for further genetic evaluation, and genetic counseling, which must proceed, even in the absence of positive genetic results. 
